Language
English
Chinese
COMPANY
About
History
Management
Benefits
Employee-Employer Relationships
Join Us
|
PRODUCT&SERVICE
Product List
CMO & CDMO
Analytical Development
Co-development on Early-stage Products
|
PLANT
Location
Tainan
Tainan Injection Plant
Inspection History
|
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
|
SLC BIOPHARM
Carbapenem
PRODUCT
Paliperidone Palmitate
Cetrorelix Acetate
Ganirelix Acetate
Plecanatide
Prucalopride Succinate
Brinzolamide
INVESTORS
Financials
Annual Reports
Shareholder Services
Press
Press
2023.06.08
/
Savior Lifetec Will Expand into Health Supplements
2021.12.30
/
Savior Lifetec Corp. Leadership Changes: Chen Zhi-Fang Appointed as General Manager, Chen Yong-Fa as Executive Director and Chief Consultant
2020.06.24
/
Savior Lifetec Corp. Chinese Name Change
2019.03.26
/
U.S. Food and Drug Administration (FDA) approved Savior’s ANDA of Ertapenem 1g in Mar, 2019.
2017.08.17
/
Savior Lifetec Co., Ltd. - Investor Conference 2017
2016.12.08
/
Savior Lifetec Co., Ltd. - Active Pharmaceutical Ingredient (API) site in Nanke, Tainan passes MHRA UK Audit
2016.11.02
/
Savior Lifetec Co., Ltd. -Active Pharmaceutical Ingredient (API) site in Chunan passes FDA US Audit
2016.10.24
/
Savior Lifetec Corporation's Injection Plant (IP) in Tainan, Taiwan Passes US FDA Audit
2016.09.29
/
Savior Lifetec Co., Ltd. --Active Pharmaceutical Ingredient (API) site in Nanke passes FDA US Audit
2016.04.28
/
Savior Lifetec Co. Receives US ANDA Approval for Meropenem
<
1
/
2
/
3
>